Development and Validation of a Grading Scale for Primary Pontine Hemorrhage

Author:

Huang Kaibin1,Ji Zhong1,Sun Lihua1,Gao Xiaoya1,Lin Shaopeng1,Liu Tao1,Xie Shanfang1,Zhang Qishan1,Xian Wenchuan1,Zhou Saijun1,Gu Youquan1,Wu Yongming1,Wang Shengnan1,Lin Zhenzhou1,Pan Suyue1

Affiliation:

1. From the Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China (K.H., Z.J., L.S., Y.W., S.W., Z.L., S.P.); Department of Neurology, The First Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China (L.S.); Department of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, China (X.G.); Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical College, China (S.L.); Department of Neurology, Hainan General Hospital,...

Abstract

Background and Purpose— We aimed to develop and validate a grading scale for predicting 30-day mortality and 90-day functional outcome in patients with primary pontine hemorrhage (PPH). Methods— We retrospectively reviewed records of consecutive patients with first-ever pontine hemorrhage from 3 teaching hospitals between 2005 and 2012. Independent factors associated with 30-day mortality were identified by logistic regression to establish a risk stratification scale, named the new PPH score. For validation of the new PPH score, we prospectively recruited subjects from 10 units between December 2014 and November 2015. The performance of the new PPH score was presented as discrimination and calibration, measured by area under the curve of the receiver operating characteristic and Hosmer–Lemeshow goodness-of-fit, respectively. Results— Data of 171 patients were available for scale development. The new PPH score consisted of 2 independent factors with individual points assigned as follows: Glasgow Coma Scale score 3 to 4 (=2 points), 5 to 7 (=1 point), and 8 to 15 (=0 point); PPH volume >10 mL (=2 points), 5 to 10 mL (=1 point), and <5 mL (=0 point). An independent cohort of 98 patients was applied as an external validation of the new PPH score. Results showed that the new PPH score was discriminative in predicting both 30-day mortality (area under the curve, 0.902) and 90-day good outcome (area under the curve, 0.927). Furthermore, the new PPH score revealed a good calibration (χ 2 =1.387; P =0.846) in 30-day mortality prediction. Conclusions— The new PPH score is simple and reliable in predicting short-term and long-term outcome for PPH patients. Clinical Trial Registration— URL: http://www.chictr.org.cn . Unique identifier: ChiCTR-OOC-14005533.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3